Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Apr 30, 2021 12:45pm
134 Views
Post# 33101830

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Magic Mushrooms

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Magic MushroomsI trust Jesus will see fit to overlook you using his name like that - you should know that many believe using the Lord's name in that manner is not going to bring you any blessings. Just looking out for your earthly and eternal welfare friend.

But, even if I had spoken to Paul, do you really think he was going to share with me all of the nasty aspects of how this deal went down. At best, I would have a hint here or there and would have to try t o piece together what actually happened. 

realitycheck4u wrote:

Geezus Krist SPCEO you could have asked Paul that when he called or at any time since. 

 

SPCEO1 wrote: I would live to know the backstory on the offering. I can't imagine Dubuc thought this was a sensible deal so I wonder if it was more a panicking board that led to the decision to move forward with the OO. I have heard twice now that there was some other offer on the table at some point, likely with a US based broker, but it fell through on some technicality. For all we know, Dubuc may have advised against doing the OO and was overridden by the board. 
 

 

palinc2000 wrote: I am reposting this  because I feel  that this weak link in managemenent needs be to fixed ASAP 


palinc2000 wrote: What makes you think Dubuc is good with numbers?The Offering was under his responsibility and every aspect was a failure.
1- Pricing of the Units
2- Issuance of Warrants 
3- Exercise Price of Warrants
4-Expiry date of Warrants
5-Share Placement in wrong Hands
6-Lack of preparedness 
etcccc 
I



Bucknelly21 wrote: On st we have about 13 new followers in the last 45 day bringing our grand total to 909. Which is unbelievably low despite all the good news we have had. While companies with nothing trading at .00004 cents a share have 80k. This just confirms what we all have been saying. They are either stupid (which I don't believe) or stubborn and don't want to admit that they are wrong in their approach to just about everything on the topic of investors. I remember years ago Phillipe had so many meetings after meeting with tutes, absolutely nothing but a pos offering came of it years later. He may be good with numbers and I pleasant man but he's not a salesman 

 

 

 




<< Previous
Bullboard Posts
Next >>